World's First 3D-Printed Immune-Compatible Material Opens New Avenues for Organ Transplants and Drug Delivery
Release time:
2025-11-28
A University of Virginia research team has pioneered a novel 3D-printable material compatible with the human immune system, as reported in the latest issue of Advanced Materials.
Breaking Bottlenecks: Stretchable PEG Material Overcomes Traditional Limitations
Based on polyethylene glycol (PEG), this innovation addresses the brittleness and crystallization issues of conventional PEG by introducing a molecular structure that maintains integrity under stretching. This breakthrough benefits medical technologies like artificial organ transplantation and drug delivery, as well as advanced battery applications. Traditional PEG production involves cross-linking polymers followed by dehydration, leading to structural weakness. The new approach mimics elastic rubber’s molecular design with a "foldable bottlebrush" structure—where flexible side chains radiate from a central backbone, folding like an accordion to store extra length and unfold for high stretchability and durability, significantly enhancing PEG-based material performance.
Technological Innovation: Light-Controlled Polymerization Enables Complex 3D Printing
By applying the "foldable bottlebrush" concept to PEG, the team used UV light exposure to trigger polymerization within seconds, producing highly stretchable PEG-based hydrogels and solvent-free elastomers suitable for 3D printing. The key advancement lies in shaping UV light to precisely control polymerization, enabling the fabrication of intricate 3D structures essential for customized artificial organ scaffolds or drug delivery systems. Tests confirm excellent biocompatibility, with cell cultures showing tissue compatibility and suitability for direct implantation, significantly reducing immune rejection risks.
Application Expansion: Cross-Disciplinary Potential from Healthcare to Energy
Beyond medical uses, the material demonstrates versatility across fields. Compared to existing solid polymer electrolytes, it offers higher conductivity and stretchability at room temperature, positioning it as a candidate for high-performance solid electrolytes in advanced batteries. The team plans to explore its application in solid-state batteries and develop composite materials with diverse chemistries to expand 3D-printed product possibilities. This achievement not only paves the way for rapid, safe organ transplantation and drug delivery technologies but also holds promise for driving innovation in energy storage and other sectors.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
